Drugs / Tinoridine
Tinoridine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01224756 | Nov 2010 → Oct 2011 | — | Takeda | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tinoridine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01224756 ↗ |
| Known as | NSC-158555 | ChEMBL registry synonym — accepted as the source's own label CHEMBL592943 ↗ |
| Known as | Tinoridina | ChEMBL registry synonym — accepted as the source's own label CHEMBL592943 ↗ |
| Known as | Y 3642 | ChEMBL registry synonym — accepted as the source's own label CHEMBL592943 ↗ |
| Modality | Small molecule | — CHEMBL592943 ↗ |
| Route | Oral | “Tinoridine HCl 50 mg, orally, 2 capsules three times daily for up to 4 days.” NCT01224756 ↗ |